1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study Article Swipe
Related Concepts
Ralph Stephan von Bardeleben
,
Paul Mahoney
,
Michael A. Morse
,
Matthew J. Price
,
Paolo Denti
,
Francesco Maisano
,
Jason H. Rogers
,
Michael Rinaldi
,
Federico De Marco
,
William Rollefson
,
Bassem Chehab
,
Mathew Williams
,
Guillaume Leurent
,
Federico M. Asch
,
Evelio Rodríguez
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.jcin.2023.09.029
· OA: W4387899887
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.jcin.2023.09.029
· OA: W4387899887
M-TEER with the fourth-generation M-TEER device was safe and effective at 1 year, with durable reductions in MR severity to ≤1+ in more than 90% of patients and concomitant improvements in functional status and quality of life.
Related Topics
Finding more related topics…